Best Liquid Therapy Podcasts (2025)

1
S13 Ep7: Evolving Molecular Profiling and Liquid Biopsy Practices Guide First-Line CRC Therapy Decisions: With Chandler Park, MD; and Midhun Malla, MD 9:09

Play Pause

5d ago9:09

9:09

Drs Park and Malla began by talking through the clinical utility of ctDNA in patients with stage II and III colon cancer. Dr Malla referenced the DYNAMIC (ACTRN12615000381583) and observational BESPOKE CRC (NCT04264702) trials, noting that ctDNA serves as a prognostic biomarker for recurrence and is increasingly used to guide post-surgical surveill…

1
Paolo Marchetti MD: Tissue or Liquid Biopsy? Both Together Could Be Best for Advanced Solid Tumor Therapy Planning 9:54

26d ago9:54

9:54

The Audio Journal of Oncology talks with: Paolo Marchetti MD, Scientific Director, Istituto Dermatopatico dell’Immacolata, Rome And with: Elaine R. Mardis, PhD FAACR, Co-Executive Director of the Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children’s Hospital, Rasmussen Nationwide Foundation Endowed Chair in Genomic Medicin…

1
S13 Ep10: Updates and Innovations in Non-Opioid Pain Management Strategies for Breast Cancer Patients Post-Surgical Intervention 1:32:30

4h ago1:32:30

1:32:30

This PER® featured podcast includes a discussion with 3 experts on best practices for integrating opioid-sparing strategies into the treatment paradigm along with updates including the 2025 NOPAIN Act. The panel includes members of the care team including the surgical oncologist and anesthesiologist. This program is designed to help clinicians reco…

1
333. Should You Stop Exfoliating in Winter? (And Other Skincare Myths Busted) 20:59

1d ago20:59

20:59

In this week’s Expert episode, things are getting chilly – but your skincare doesn’t have to suffer. Skin therapist and co-host Tegan busts some of winter’s biggest skin myths: Do you still need SPF in June? Is it time to ditch exfoliants? And does dry skin really mean you need to slather on the thickest cream in your stash? Before that, in Win, Bi…

1
S13 Ep9: Multidisciplinary Collaboration and Mentorship Lay the Foundation for a New Chapter of ASCO Leadership: With Elizabeth Mittendorf, MD, PhD, MHCM 12:53

1d ago12:53

12:53

In today’s episode, we had the pleasure of speaking with Elizabeth Mittendorf, MD, PhD, MHCM, the 2026 president-elect of ASCO. Dr Mittendorf is the Robert and Karen Hale Distinguished Chair in Surgical Oncology and the vice chair for research in the Department of Surgery at the Brigham and Women's Hospital; co-leader of the Breast Program and dire…

1
S13 Ep8: Oncology PER® Spectives: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma 54:11

1d ago54:11

54:11

This Oncology PER®Spectives™ podcast examines the recent advancements in the treatment landscape for advanced melanoma.In this activity, expertsYana Najjar, MD; Rahul A. Sheth, MD, FSIR; and Douglas Johnson, MD, MSCI, discuss the challenges of immune checkpoint inhibitor resistance and the practical strategies for overcoming this by using direct in…

1
332. Hyaluronic Acid Serums Under $100, SPF Top-Ups & Hannah's Steam Iron 36:56

3d ago36:56

36:56

This week’s Uncensored ep is serving hydration hits, sun safety smarts, and... a surprise steamer rec you didn’t know you needed (but definitely do). The Top 3: We’re spotlighting the most-loved hyaluronic acid serums under $100, based on what Adore Beauty customers are actually buying. Think grippy textures, glow-boosting formulas, and beauty edit…

1
S13 Ep6: FDA Approval Insights: Perioperative Durvalumab Plus Chemo in MIBC: With Matthew Galsky, MD 7:48

6d ago7:48

7:48

In today’s episode, we spoke with Matthew Galsky, MD, about the FDA approval of neoadjuvant durvalumab (Imfinzi) plus gemcitabine and cisplatin followed by adjuvant durvalumab monotherapy after radical cystectomy for the treatment of adult patients with muscle-invasive bladder cancer (MIBC). Dr Galsky is a professor of medicine (hematology and medi…

1
331. Do LED Face Masks Actually Work? The Truth About Red Light Therapy 28:26

8d ago28:26

28:26

You’ve seen them all over your feed: those glowing, slightly terrifying LED face masks that promise clearer, firmer, glowier skin. But do they actually work? And if so, which one is worth your dollars? In this Expert episode, we’re diving into the booming world of red light therapy and LED face masks. Skin therapist Tegan breaks down the science be…

1
S13 Ep5: Social Media Expands Access to Practical Public Health Education: With Chandler Park, MD; and Paul Hanona, MD 8:56

9d ago8:56

8:56

In this week’s episode of MedNews Week’s Oncology Unplugged, host Chandler Park, MD, a medical oncologist at Norton Cancer Institute in Louisville, Kentucky, was rejoined by Paul Hanona, MD, to give advice to up-and-coming oncology content creators. Dr Hanona is a content creator under the handle @doctordiscover. In the final part of this 3-part se…

1
330. Dry Skin Saviours, Liquid Gold 2.0 & The Cleaning TikToks We Can't Stop Watching 29:49

10d ago29:49

29:49

Mel’s leaky boobs, a skincare cult classic gets a glow-up, and a listener begs for a winter skin rescue — it’s all happening on Uncensored this week. In We Tried It, we get our hands on the new and improved Alpha-H Liquid Gold Exfoliating Treatment with Vitamin C. The original cult exfoliant just got a brightening, antioxidant-rich upgrade, but is …

1
Oxidative Stress, Healthy Longevity, and ESS60 1:41:48

11d ago1:41:48

1:41:48

Today we discuss the carbon molecule ESS60 and it's applications for Oxidated Stress, Longevity of life, and more: Scott Mulvaney and Chris Burris discuss the health benefits of ESS60, a Nobel Prize-winning molecule discovered in 1985. ESS60, a spherical molecule of 60 carbon atoms, was found to extend the life of Wistar rats by 90% when dissolved …

1
S13 Ep4: Eltrombopag Biosimilar Improves Accessibility for Immune Thrombocytopenia & Aplastic Anemia: With Kanwarpal S. Kahlon, MD 8:24

12d ago8:24

8:24

In today’s episode, supported by Camber Pharmaceuticals, we spoke with Kanwarpal S. Kahlon, MD, an associate clinical professor of medicine at the UCLA School of Medicine. In our exclusive interview, Dr Kahlon discussed the significance of the commercial availability of the generic, AB-rated formulations of eltrombopag (Promacta), a bioequivalent m…

1
Single-cell RNA Sequencing Provides Comprehensive Map of Acute Myeloid Leukemia Cell States 15:01

13d ago15:01

15:01

An interview with: Andy Zeng, MD/PhD candidate, University of Toronto and Princess Margaret Cancer Centre, Toronto, Canada With comment from: Hussein A Abbas MD PhD, Assistant Professor, Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston TX CHICAGO—A research study using single-cell RNA sequencing data has created a new …

1
329. The Reason Your Lips Are Always Dry (And It’s Not the Weather) 23:09

15d ago23:09

23:09

We’re back with part two of our skin barrier series in this week’s Expert ep. This time, we’re zooming in on your lips. If you’re reapplying lip balm 17 times a day and still waking up with crusty, cracked lips… we need to talk. Co-hosts Tegan and Sadaf break down the science behind lip barrier damage, why your trusty balm might be making things wo…

1
The METAL MEN Brotherhood with Will Henshall 1:33:20

16d ago1:33:20

1:33:20

A Brotherhood of MEN Inspiring MEN: Will Henshall is a multifaceted business leader and one of the leaders of the "METAL MEN." community. The "METAL." community is described as a men's group focused on inspiration, adventure, and brotherhood, with a membership of around 350 men. Henshall shares his background, including his success with the band Lo…

1
S13 Ep3: Updated Nilotinib Formulation Improves Treatment Adherence in Ph+ CML: With Michael J. Mauro, MD 12:59

15d ago12:59

12:59

In today’s episode, supported by Azurity Pharmaceuticals, we spoke with Michael J. Mauro, MD, about treatment adherence with nilotinib (Tasigna/Danziten) in patients with Philadelphia chromosome (Ph)–positive chronic myeloid leukemia (CML). Dr Mauro is an attending physician at Memorial Sloan Kettering Cancer Center in New York, New York. In our ex…

1
S13 Ep2: Tailored Treatment Approaches for Older Patients With Advanced HR+/HER2– Breast Cancer 49:30

16d ago49:30

49:30

This featured podcast includes a discussion with 3 experts on managing patients with hormone receptor–positive/HER2-negative (HR+/HER2–) metastatic breast cancer (mBC) from a satellite symposium held in conjunction with the 42nd Annual Miami Breast Cancer Conference® in March 2025. In observational studies of treatment patterns in older women with …

1
328. Unpacking "Recession Hair" & Your Retinol Questions Answered by Medik8’s Daniel Isaacs 33:38

17d ago33:38

33:38

Is “Recession Hair” the new quiet luxury? This week on Uncensored, we’re unpacking one of 2025’s biggest beauty trends — born from tighter budgets, longer salon gaps, and a shift toward healthy, low-maintenance hair. From grown-out roots to DIY glosses, Hannah and Mel explore how economic uncertainty is shaping the way we colour, cut, and care for …

1
Expanding Cell Therapy – TILs, TCRs & CARs in Lung Cancer and Melanoma 1:10

19d ago1:10

1:10

Welcome to another episode of the VJ Oncology Podcast, where we bring you the forefront of cancer research and clinical practice. This week, we focus on the revolutionary field of cell therapy for solid tumors, with particular emphasis on lung cancer and melanoma, as discussed during the 7th International Workshop on CAR-T and bispecifics (iwCAR-T)…

1
S13 Ep1: Cancer Vaccines Shake Up Disease Management and Prevention Strategies: With Shubham Pant, MD, MBBS; and Professor Timothy Elliott 24:09

19d ago24:09

24:09

In today’s episode, we spoke with Shubham Pant, MD, MBBS, and Professor Timothy Elliott, about ongoing research with cancer vaccines. Dr Pant is a professor in the Department of Gastrointestinal Medical Oncology in the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston. Dr Elliott is the Kidani Professor of …

1
S12 Ep50: Optimizing Today and Looking to Tomorrow in Metastatic CRPC - Homing in on EZH2 43:33

21d ago43:33

43:33

This Oncology PER®Spectives™ podcast explores the role of EZH2 in metastatic castration-resistant prostate cancer (mCRPC) progression and its synergy with androgen receptor inhibitors. In this podcast, experts Neeraj Agarwal, MD, FASCO; Himisha Beltran, MD; and Maha Hussain, MD, FACP, FASCO, discuss the management of mCRPC. Acknowledgment of Educat…

1
Yelena Y Janjigian MD: PD-1 Blockade Directed by ctDNA Delayed Recurrence in Mismatch Repair Deficient Solid Tumors After Surgery and Standard of Care 9:47

22d ago9:47

9:47

An interview with: Yelena Y Janjigian MD, Medical Oncologist, Chief of Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center, New York. CHICAGO, USA—Patients with early-stage solid cancers with DNA mismatch repair-deficiency (also known as microsatellite instability) benefitted greatly if they received anti-programmed death-1 (P…

1
327. Sensitive or Sensitised Skin? How to Tell and What to Do About It 27:32

22d ago27:32

27:32

Think your skin is sensitive? It might be… but it might also just be sensitised. And yes, there’s a big difference – one that could totally change how you treat your skin. In this Expert episode, Sadaf and Tegan unpack the key differences between true sensitive skin (like eczema, rosacea or a lifelong reactive skin type) and sensitised skin (which …

1
S12 Ep49: MEK Inhibitors Expand the NF1-Associated PN Treatment Paradigm: With Christopher L. Moertel, MD 12:54

22d ago12:54

12:54

In today’s episode, supported by SpringWorks Therapeutics, we spoke with Christopher L. Moertel, MD, about the evolution of treatments for neurofibromatosis type 1 (NF1)–associated plexiform neurofibromas (PN). Dr Moertel is a professor and the Pediatric Neuro-Oncology Fellowship Program director in the Division of Pediatric Hematology/Oncology, a …

1
S12 Ep48: Innovations in HR+/HER2– Metastatic Breast Cancer: Advancing Care Through PROTAC ER Degradation 1:17:00

23d ago1:17:00

1:17:00

This featured podcast includes a data review and candid conversation with 4 experts on challenges in the current treatment paradigm for hormone receptor–positive/HER2-negative (HR+/HER2–) metastatic breast cancer (mBC) due to endocrine resistance. This session occurred during a satellite symposium held in conjunction with the 42nd Annual Miami Brea…

1
326. Skin Prep, Sleeping Masks, Serums & "Hot Man Smell" Hair Masks 37:05

24d ago37:05

37:05

This week on Uncensored, we're asking the big questions: how many skin prep steps is too many before makeup? Mikayla Nogueira’s five-step routine has us spiralling (and yes, we read the ingredient lists). Also, intrusive beauty thoughts—lash trimming? Bangs?? Help. Then, we’re diving into the Top 3 sleeping masks trending on Adore Beauty right now.…

1
S12 Ep47: Early-Phase RAS Inhibitor Research Sparks Interest in NSCLC: With Kathryn C. Arbour, MD 9:43

26d ago9:43

9:43

In today’s episode, supported by Revolution Medicines, we spoke with Kathryn C. Arbour, MD, a thoracic medical oncologist at Memorial Sloan Kettering Cancer Center in New York, New York, about 2 important abstracts presented at the 2024 AACR Annual Meeting that explore novel RAS-targeted approaches in non–small cell lung cancer (NSCLC). Our discuss…

1
Patients with Relapsed or Refractory Acute Myeloid Leukemia have Remissions with “Logic Gated” Off-the-Shelf Natural Killer Cell Therapy 14:12

27d ago14:12

14:12

An Interview with: Stephen Strickland, Jr. MD MSCI, Director, Leukemia Research; Executive Chair, Leukemia Research Committee, Sarah Cannon Research Instiute, Nashville, Tennessee USA CHICAGO – Several patients with acute myeloid leukemia, who were treated with SENTI-202, a first-in-class chimeric antigen receptor (CAR) natural killer (NK) cell the…

1
S12 Ep46: Managing Side Effects and Fertility for Premenopausal Patients with Advanced HR+ Breast Cancer 1:04:27

27d ago1:04:27

1:04:27

This expert podcast includes an engaging discussion among 3 experts on fertility care of patients with breast cancer. This program is designed to help clinicians better recognize and take steps to discuss fertility options in premenopausal patients with hormone receptor-positive (HR+) breast cancer to facilitate care for those women who wish to pre…

1
More Breast Cancer Cases in Younger Women since 2010 But Fewer Deaths 14:50

28d ago14:50

14:50

An interview with: Adetunji T. Toriola, MD, PhD, MPH, Professor of Surgery, Department of Surgery and Division of Public Health Sciences, Washington University School of Medicine and Siteman Cancer Center, St Louis, Missouri, USA And with: Elaine R. Mardis, PhD FAACR, Co-executive director of the Steve and Cindy Rasmussen Institute for Genomic Medi…

1
325. Centella Asiatica: K-Beauty’s Skin Barrier Hero or TikTok Hype? 18:43

29d ago18:43

18:43

Centella Asiatica (aka Tiger Grass) has taken over skincare shelves, but what does it actually do? This week on Expert, we break down the science behind this centuries-old ingredient and why it's a barrier repair MVP. From healing support to anti-inflammatory power, we explain why it’s trending (again) and who should use it. Plus, in Adore Anonymou…

1
Fast, Accurate Artificial Intelligence Method to Diagnose and Classify Pediatric Sarcoma Anywhere 15:56

29d ago15:56

15:56

An interview with: Adam Thiesen, PhD Candidate, UConn Health, University of Connecticut and the Jackson Laboratory for Genomic Medicine, Farmington, CT And with: Jayesh Desai MD, Medical Oncologist, Associate Director Clinical Research, Peter MacCallum Cancer Centre, Melbourne, Australia, Co-Chair, AACR Clinical Committee. CHICAGO – An artificial i…

1
S12 Ep45: RP1 Plus Nivolumab Delivers Durable Responses in PD-1–Exposed Melanoma: With Anna C. Pavlick, BSN, MSc, DO, MBA 10:56

29d ago10:56

10:56

In today’s episode, supported by Replimune, we had the pleasure of speaking with Anna C. Pavlick, BSN, MSc, DO, MBA, about the use of RP1 plus nivolumab (Opdivo) for the treatment of patients with advanced melanoma. Dr Pavlick is a professor of medicine in the Division of Hematology & Medical Oncology at Weill Cornell Medicine in New York, New York…

1
EGFR-Sparing Anti-HER2 Drug Benefits Patients with Advanced HER2-Mutated Non-Small Cell Lung Cancer 12:59

1M ago12:59

12:59

An interview with: John V Heymach MD PhD, Professor and Chair of Thoracic/Head and Neck Medical Oncology, Ruth Legett Jones Distinguished Chair, University of Texas MD Anderson Cancer Center, Houston TX And with: Jayesh Desai MD, Medical Oncologist, Associate Director Clinical Research, Peter MacCallum Cancer Centre, Melbourne, Australia, Co-Chair,…

1
324. Botox Myths, Crusty Lips & We Try Bondi Sands’ New 1-Hour Tan 25:40

1M ago25:40

25:40

This week on Uncensored, we bust viral Botox myths (thanks to TikTok’s fave NYC derm), help a listener repair their dry, crusty lips, and test Bondi Sands’ new Ultra Express tan that promises deep colour in just one hour. Plus, Doechi is making face tape fashion, and we review the Mediheal toner pads all over our TikTok feeds. Everything Mentioned:…

1
Neoadjuvant PD-1 Blockade Enables Patients with Mismatch Repair Deficient Colorectal Cancers to Avoid Surgery 14:03

1M ago14:03

14:03

An interview with: Andrea Cercek MD, Gastrointestinal Cancer Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York And: Ryan B Corcoran MD PhD, Director of the GI Cancer Program, Massachusetts General Hospital Cancer Center, Boston MA CHICAGO—The Audio Journal of Oncology reports on the neoadjuvant use of programmed cell-death protei…

1
Topical BRAF-inhibiting Gel Controls Acneiform Rash in Patients with Colorectal Cancer Treated with EGFR-inhibition 8:45

1M ago8:45

8:45

An interview with: Anisha B Patel MD, Associate Professor of Dermatology, Division of Internal Medicine, MD Anderson Cancer Center, Houston TX CHICAGO, USA—Acneiform rash toxicities caused by anti- epidermal growth factor receptor (EGFR) therapies were markedly reduced among patients with colorectal cancer in a double-blind placebo-controlled, rand…

1
S12 Ep44: Real-World Data Support Nadofaragene Firadenovec Use in BCG-Unresponsive NMIBC: With Jacob Moyer, BS; and Mark D. Tyson, II, MD, MPH 12:33

1M ago12:33

12:33

In today’s episode, we had the pleasure of speaking with Jacob Moyer, BS, and Mark Tyson II, MD, MPH, about a real-world study investigating nadofaragene firadenovec in patients with BCG-unresponsive NMIBC. Moyer is a graduate researcher at Mayo Clinic in Scottsdale, Arizona. Tyson is a urologic oncologist and an associate professor of urology at t…

1
Adding Perioperative Pembrolizumab to Standard of Care Improves Outcomes in Patients with Newly Diagnosed Head and Neck Cancers 13:26

1M ago13:26

13:26

Interviews with: Ravindra Uppaluri, MD PhD, Director of Head and Neck Surgical Oncology, Dana Farber Brigham Cancer Center, Boston MA; And: Ryan B Corcoran MD PhD, Director of the gastrointestinal cancer program, Massachusetts General Hospital Cancer Center, Associate Professor of Medicine Harvard Medical School and Co-Chair of the American Associa…

1
RAS Inhibitor Zoldonrasib Brings Clinical Benefit in Patients with G12D Mutated Non-Small Cell Advanced Lung Cancer 12:15

1M ago12:15

12:15

An interview with: Kathryn C Arbour MD, Thoracic Medical Oncologist, Memorial Sloan Kettering Cancer Center, New York USA And: Ryan B Corcoran MD PhD, Massachusetts General Cancer Center, Associate Professor of Medicine Harvard Medical School, Co-Chair, American Association for Cancer Research Clinical Trials Committee CHICAGO, USA— The four per ce…

1
323. Beauty Supplements in 2025: Gut Health, Sustainability & Smarter Formulas 29:56

1M ago29:56

29:56

This week on Expert, we're getting real about beauty supplements — what’s changed, what’s next, and which ones are actually worth your cash. From the gut-skin-brain connection to smarter, more sustainable formulas, we’re breaking it all down. Plus, meet the newest cult supplement brand to hit Adore Beauty’s shelves. In Win, Bin or Recycle, we ask t…

1
S12 Ep43: Disease Features and Treatment Intolerance Inform Pirtobrutinib Use in Pretreated CLL: With Nicole Lamanna, MD 19:32

1M ago19:32

19:32

In today’s episode, we had the pleasure of speaking with Nicole Lamanna, MD, about patient selection considerations for the use of pirtobrutinib (Jaypirca) in the management of chronic lymphocytic leukemia (CLL). Dr Lamanna is a hematologic oncologist at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Irvi…

1
322. Inside Makeup Artist Elizabeth Cee’s Beauty Bag + Viral Haircare Routine 46:11

1M ago46:11

46:11

This week on Uncensored, we’re talking braces (yes, braces because apparently they're cool again??), Mel's three Brazilian non-negotiables, and Mother’s Day beauty cart builds — all in one jam-packed episode. First up, it's Top 3, where we dig into Adore Beauty’s data to uncover the most coveted products by category. On the list this week? Hair smo…

1
VJOncoAlert Journal Club 21:33

1M ago21:33

21:33

In this week’s podcast, we take you through the latest episodes of the VJOncoAlert Journal Club—a collaborative series from VJOncology and OncoAlert that brings together leading oncology experts to discuss the most impactful and practice-changing research in the field. We are joined by Misty Shields, MD, PhD, from the Indiana University Simon Compr…

1
S12 Ep42: Radioligand Therapy Advances Represent the Future of mCRPC Treatment: With Daniel P. Petrylak, MD 7:28

1M ago7:28

7:28

In today’s episode, we had the pleasure of speaking with Daniel P. Petrylak, MD, about Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) in metastatic castration-resistant prostate cancer (mCRPC). Dr Petrylak is a professor of medicine (medical oncology) and urology, as well as the chief of Genitourinary Oncology, at Yale School of Medicine and Smil…

1
S12 Ep41: Oncodetect MRD Detection Aids Treatment Decision-Making in CRC and Other Solid Tumors: With Eric Christenson, MD 13:53

1M ago13:53

13:53

In today’s episode, supported by Exact Sciences, we had the pleasure of speaking with Eric Christenson, MD, about the Oncodetect test, which is available for use in molecular residual disease detection in patients with solid tumors. Dr Christenson is an assistant professor of oncology at the Johns Hopkins School of Medicine in Baltimore, Maryland. …

1
Two Checkpoint Inhibitors in One Bispecific Molecule Improved Survival in Patients with High-Risk Gastric Cancer 10:10

1M ago10:10

10:10

An interview with: Jiafu Ji MD PhD DrPH FRCS, Fellow of the Chinese Academy of Medical Science, Professor and Chief, Gastrointestinal Cancer Center, Peking University Cancer Hospital, Beijing Institute for Cancer Research, Beijing, China Sarah Maxwell, Audio Journal of Oncology: The idea of harnessing two different pathways of checkpoint inhibition…

1
321. The Best Body Skin Care & Treatments in 2025: Smooth, Firm & Sculpt Your Skin 22:34

1M ago22:34

22:34

We’re giving the skin below your chin some well-deserved love in this week’s Expert episode—from in-clinic treatments that sound like they belong in a sci-fi flick, to at-home body care solutions that actually deliver results. Think firming creams, LED gadgets, and exfoliants that’ll have you feeling dolphin-smooth in no time. But first, it’s Win, …

1
Headache Advantage with Dr. Scott Vrzal 1:04:18

1M ago1:04:18

1:04:18

Healing Headaches By Understanding The Origins of Your Pain: The hosts today discuss the common issue of headaches and the role of chiropractic care. Dr. Vrzal, a chiropractor with over 30 years of experience, shares his personal journey with headaches and his advocacy for drug-free, holistic solutions. He explains the seven specific headache patte…